1. Home
  2. NTRA vs FIS Comparison

NTRA vs FIS Comparison

Compare NTRA & FIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$231.21

Market Cap

32.9B

Sector

Health Care

ML Signal

HOLD

Logo Fidelity National Information Services Inc.

FIS

Fidelity National Information Services Inc.

HOLD

Current Price

$54.93

Market Cap

34.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
FIS
Founded
2003
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
32.9B
34.0B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
FIS
Price
$231.21
$54.93
Analyst Decision
Strong Buy
Buy
Analyst Count
15
18
Target Price
$249.53
$83.82
AVG Volume (30 Days)
1.1M
3.5M
Earning Date
02-26-2026
02-13-2026
Dividend Yield
N/A
2.90%
EPS Growth
N/A
N/A
EPS
N/A
0.29
Revenue
$2,116,676,000.00
$10,464,000,000.00
Revenue This Year
$33.77
$5.82
Revenue Next Year
$16.92
$6.75
P/E Ratio
N/A
$190.58
Revenue Growth
38.17
4.21
52 Week Low
$125.38
$54.65
52 Week High
$256.36
$83.97

Technical Indicators

Market Signals
Indicator
NTRA
FIS
Relative Strength Index (RSI) 44.72 18.65
Support Level $229.14 $59.95
Resistance Level $250.00 $66.73
Average True Range (ATR) 8.27 1.78
MACD -1.38 -0.90
Stochastic Oscillator 21.29 4.26

Price Performance

Historical Comparison
NTRA
FIS

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About FIS Fidelity National Information Services Inc.

Fidelity National Information Services provides core processing and ancillary services to banks, but its business has expanded over time. By acquiring SunGard in 2015, the company now provides record-keeping and other services to investment firms. With the acquisition of Worldpay in 2019, FIS was providing payment processing services for merchants and holding leading positions in the United States and United Kingdom. But the company sold off a majority interest in Worldpay and now has only a minority stake.

Share on Social Networks: